World Scleroderma Foundation (WSF) Summer School Pulmonary Arterial Hypertension (PAH)- in depth course Thu 23 June- Sun 26 June 2011 Location: Villa Medicea La Ferdinanda & Villaggio di “Artimino”, Florence, Tuscany, Italy Background WSF, World Scleroderma Foundation, has been considering for some time the need for an “in-depth” course to enable rheumatologists to truly expand their knowledge in the field of pulmonary vascular disease (PVD), particularly in the pathophysiology and diagnosis with relation to the scleroderma patients they see. WSF would appreciate support in the delivery of this meeting and are looking for a sponsor to support financially (to cover some general costs, development of video content plus a bank of “train the trainer” materials. These will allow the meeting to be more broadly replicated/executed). Objectives 1. General Provide a vehicle for expanding expertise ( Scleroderma PAH) in the rheumatology community Developing future experts and excellence in the field of Scleroderma and PVD Encourage cross speciality (Pulmonology, Cardiology, Connective Tissue Pathology) networking by involving “highest” experts in the field of PAH Developing an alumni of experts who can transfer their knowledge and improve skills at a local country level worldwide 2. Specific Content for this meeting focussed on Scleroderma and PVD to allow depth of learning and discussion in this disease area Interactive format to aid networking and learning Practical, discussion and plenary to address diversity of learning styles Use of patients and patient cases to support practical application of learning Production of materials to enable “excellent” replication 3. Long term Replicate template and core content to support education and training on Scleroderma PAH across the global community Maintaining and increasing size of alumni Requirements 3 day meeting (Thursday noon to Sunday noon) Rental of Echo machines Video capability or satellite links to expert centres Venue to accommodate 80-100 (30 students, 20-30 teachers, technicians, companies) Production of a bank of training materials (meeting presentations, videos and discussion guides) for use during and post the meeting World Scleroderma Foundation Steering Committee A Tyndall, Dan Furst, Marco Matucci Cerinic Local Organizing Committee Serena Guiducci, Silvia Bellando Randone, Cinzia Pruneti Board 1. R Abbate 2. M Aringer 3. Y Allanore 4. J Coghlan 5. M D’Alto* 6. O Distler 7. J Easaw* 8. D Furst 9. N Galiè 10. L Gargani* 11. G F Gensini 12. H Gruenig 13. E Hachulla 14. S Harari 15. D Khanna 16. O Kowal Bielecka 17. M Matucci Cerinic 18. U Muller Ladner 19. R Naeje 20. A Pignone 21. J Seibold 22. JL Vachiery 23. G Valentini 24. P Vitulo 25. D Vizza* 26. F Wigley *Tutors Scientific Programme Thursday : 15h00- 19h00 Welcome- The World Scleroderma Foundation (WSF) M Matucci Cerinic & Dan Furst Wellcome- The University of Florence Gian Franco Gensini, Dean, University of Florence Pre-meeting MCQ test S Guiducci & S Bellando Randone Learning objectives of the course D Furst Eustar data on PAH (database) (15’) U Muller Ladner Lecture : Pathophysiology of lung circulation R Naeje (30’) Session 1. 2. 3. 4. 5. PH-PAH definition / classification in SSc (30’) A Ghofrani ESR PAH Guidelines (20’) N Galiè Genetics of PAH and SSc PAH (20’) Y Allanore The screening of SSc PAH E Hachulla Outcome measures in SSc PAH D Furst Friday MORNING SSc- CLINICAL ASPECTS 8.30-9.30 Clinical aspects of SSc PAH : when to suspect ? in depth analysis of the symptoms (dyspnea, heart failure) J Seibold- C Denton 9.30-10.30 Heart involvement in SSc : focus on myocardiopathy and diastolic dysfunction, differential diagnosis of PAH in SSc G Valentini- Y Allanore 10.30-11.00 BREAK 11-12 Lung involvement: prevalence, patterns, imaging subgroup at risk, disproportionate PAH, Differential outcomes of PAH vs ILD associated PAH D Khanna- O Kowal 12-12.30 Lecture- PAH pathogenesis in SSc O Distler 12.30-14.00 Lunch AFTERNOON- Practical workshops (movies and practice) 14.00-15.00 Pulmonary functional tests: useful parameters in PAH-SSc S Harari o MOVIE- PFTs recorded S Harari 15.00-16.00 Doppler echocardiography : fundamental parameters, parameters useful for the diagnosis and prognosis of PAH, pitfalls D Vizza, L Gargani 16.00-16.30 BREAK 16.30-18.30 Exercise echo , yes or no ? A Pignone o HANDS ON- Doppler echocardiography on patients: D Vizza, L Gargani, M D’Alto, J Easaw Saturday MORNING 8.30-9.30 Practical workshops (movies and practice) RHC how to interpret the results J Coghlan o MOVIE- Catheterization recorded- J Coghlan Break 11.00-13.00 o HANDS ON- Doppler echocardiography on patients: D Vizza, L Gargani, M D’Alto, J Easaw 13-14.30 lunch AFTERNOON TREATMENT 14.30-18.00 Update on PAH- Future molecular targets JL Vachiery Current view of the treatment of iPAH M Humbert Lung Transplantation in PAH P Vitulo Current view of the treatment of SSc-PAH & Overall strategy C Denton Prostanoids in PAH F Wigley ERAs in PAH J Seibold PD5 in PAH JL Vachiery Combination therapy M D’Alto Coagulation, yes or no ? R Abbate Supportive care H Gruenig Sunday : MORNING Post meeting test o Difficult cases of SSc-PAH- presentations from young investigators 1. Pericarditis masking PAH 2. Diastolic dysfunction 3. Young patients with severe form and discussion of transplantation 4. Venous involvement